Page last updated: 2024-12-06

hexocyclium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Hexocyclium is a quaternary ammonium compound that acts as a muscarinic acetylcholine receptor antagonist. It was synthesized in the 1950s and was initially studied for its potential therapeutic use in treating various conditions, including peptic ulcer disease, Parkinson's disease, and motion sickness. However, due to its side effects and the availability of more effective medications, hexocyclium is no longer widely used clinically. Research on hexocyclium has focused on its pharmacological properties, particularly its interaction with muscarinic receptors, and its potential for therapeutic applications. Studies have investigated its ability to block acetylcholine signaling, leading to effects like decreased gastric acid secretion, reduced smooth muscle contractions, and altered neurotransmission. Despite its limited clinical use, hexocyclium remains a valuable research tool for understanding the role of muscarinic receptors in various physiological processes and for developing new therapeutic agents that target these receptors.'

hexocyclium: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24199
CHEMBL ID1201325
CHEBI ID5707
SCHEMBL ID934371
MeSH IDM0065562

Synonyms (27)

Synonym
gtpl323
piperazinium, 4-(2-cyclohexyl-2-hydroxy-2-phenylethyl)-1,1-dimethyl-
hexocyclum
piperazinium, 4-(beta-cyclohexyl-beta-hydroxyphenethyl)-1,1-dimethyl-, sulfate
4-(2-cyclohexyl-2-hydroxy-2-phenethyl)-1,1-dimethylpiperazinium
C07811
6004-98-4
hexocyclium
L023949
AC1L2NA2 ,
1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylethanol
bdbm81959
cas_115-63-9
hexocyclium ion
hexocyclium cation
chebi:5707 ,
CHEMBL1201325 ,
ll3147pi1t ,
unii-ll3147pi1t
4-(.beta.-cyclohexyl-.beta.-hydroxyphenethyl)-1,1-dimethylpiperazinum
hexocyclium [who-dd]
SCHEMBL934371
surecn934371
1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenyl-ethanol
DB06787
Q5749037
DTXSID80859210

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Prolonged-release dosage forms of these drugs produced effects comparable to those produced by much smaller doses in conventional tablets and gave no indication of providing prolonged anticholinergic effects."( Biopharmaceutic factors that influence effects of anticholinergic drugs: comparison of propantheline, hexocyclium, and isopropamide.
Gibaldi, M; Grundhofer, B, 1977
)
0.47
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amineA compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1345189Rat M1 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (78.95)18.7374
1990's3 (15.79)18.2507
2000's1 (5.26)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.35 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.01 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]